Clinical Trials Logo

Clinical Trial Summary

To determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in patients who have a history of worsening asthma after exercise.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00245570
Study type Interventional
Source Organon and Co
Contact
Status Completed
Phase Phase 3
Start date December 2005
Completion date September 2006

See also
  Status Clinical Trial Phase
Completed NCT04302610 - Do Heat and Moisture Exchange Mask Reduce EIB and Cough Severity in Asthma N/A
Completed NCT00777348 - To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol Phase 2
Completed NCT00664937 - Exercise Induced Bronchoconstriction (0476-359) Phase 1
Completed NCT00090142 - Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275) Phase 3
Completed NCT03840044 - The Effect of Physical Exercise in a Cold Air Environment on Normal Volunteers and Asthmatic Patients N/A
Completed NCT00092131 - Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270) Phase 3
Recruiting NCT05105529 - Adaptation to Ozone in Individuals With Asthma/Exercise-induced Bronchoconstriction N/A
Recruiting NCT06245551 - A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma Phase 3
Not yet recruiting NCT03327701 - The Effect of Benralizumab on Exercise-induced Bronchoconstriction Phase 3
Recruiting NCT00916773 - Pulmonary Disorders During Exercise in Patients With Obstructive Sleep Apnea N/A